Source news

moneycontrol News

20 stories
moneycontrol

Nibe CEO Prakash Hari Khose steps down; stock slips nearly 3%

Shares of Nibe Ltd fell nearly 3% in morning trade on Monday after the defence and aerospace manufacturer announced the resignation of its Chief Executive Officer and Key Managerial Personnel, Prakash Hari Khose.The stock was trading at Rs 1,610, down 2.79%.In an exchange filing, the company said K…

Moneycontrol en
Stocks IN
moneycontrol

Buy Astral; target of Rs 1710: Motilal Oswal

Motilal Oswal's research report on AstralAstral’s (ASTRA) Board has approved the business restructuring plan to consolidate its Plumbing and Chemical businesses into separate entities. It will take 9-12 months to complete the demerger process. The large capex cycle is behind, and ASTRA aims to grow…

Moneycontrol en
Stocks IN
moneycontrol

Dr Reddy's Laboratories shares extend rise to 6th day on high volumes

Dr Reddy's Laboratories shares extended their gaining streak to the sixth consecutive session on Monday, emerging among the top performers on the Nifty50 index.The stock gained after the US drug regulator completed an inspection at the company's biologics facility in Bachupally, Hyderabad, and issu…

Moneycontrol en
Stocks IN
moneycontrol

Buy Persistent Systems; target of Rs 6200: Motilal Oswal

Motilal Oswal's research report on Persistent SystemsPersistent Systems announced two strategic developments: (1) the acquisition of Nagarro for an enterprise value of €1.27b, and (2) a new USD650m+ services contract over 6.5 years with an existing US-based technology customer. Nagarro adds ~USD1.1…

Moneycontrol en
Stocks IN
moneycontrol

Neutral Tata Capital; target of Rs 390: Motilal Oswal

Motilal Oswal's research report on Tata CapitalTata Capital (TCL) is among India’s leading diversified NBFCs, with an AUM of INR2.77t as of Mar’26. The company has delivered a robust ~29% AUM CAGR (excluding Motor Finance) over FY23-26, reflecting the strength of its franchise, diversified business…

Moneycontrol en
Stocks IN
moneycontrol

Buy Astral; target of Rs 1779: Prabhudas Lilladher

Prabhudas Lilladher's research report on AstralAstral Ltd has announced the demerger of its businesses into Astral Ltd. (Plumbing) and Astral Chemie (Adhesives, Paints & Specialty Chemicals), wherein management outlined the strategic rationale behind creating two focused entities with independent c…

Moneycontrol en
Stocks IN
NEWS moneycontrol

Currency Check: Rupee gains 5 paise at open amid stable oil prices

The Indian rupee opened with a marginal gains on June 29, with fresh U.S.-Iran hostilities having little impact on oil prices, risk appetite and Asian currencies.The rupee opened 5paise higher at 94.35 against the US dollar on Monday, compared to Thursday's close of 94.40.According to Finrex, the I…

Moneycontrol en
Forex
moneycontrol

Buy Persistent Systems; target of Rs 6400: Prabhudas Lilladher

Prabhudas Lilladher's research report on Persistent SystemsThe investments (USD 1.6bn) in Nagarro is largely complementing and scaling the core business dynamics of PSYS, in terms of expanding new verticals and geographies, where PSYS has marginal presence. More importantly, the target entity share…

Moneycontrol en
Stocks IN
NEWS moneycontrol

Commodity Corner: Oil, gold decline as geopolitical risks ease; dollar remains in focus

Commodity markets traded lower on June 29 as easing geopolitical tensions in the Middle East and a stronger US dollar weighed on investor sentiment.Oil prices pared early gains after the US and Iran agreed to halt attacks on each other following weekend flare-ups that saw an oil supertanker struck…

Moneycontrol en
Futures

PFC falls nearly 2%, REC dips after boards clear merger scheme

PFC and REC shares traded lower in early deals on Monday after the state-run lenders approved their long-awaited merger scheme to create a power sector financing giant with a combined loan book of over Rs 11 lakh crore. PFC shares were down 1.83% at Rs 424.75, while REC declined 0.32% to Rs 363.50…

Moneycontrol en
Stocks IN
moneycontrol

Indoco Remedies in focus after Goa plant receives EU GMP certification

Shares of Indoco Remedies are likely to remain in focus after the company said its solid oral dosage manufacturing facility (Plant I) in Goa has received EU Good Manufacturing Practice (GMP) certification from the Malta Medicines Authority.The certification follows an inspection conducted by the re…

Moneycontrol en
Stocks IN
moneycontrol

Lupin gains after USFDA grants tentative approval for Enzalutamide tablets

Shares of Lupin will be in focus after the drugmaker said it has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Enzalutamide Tablets in strengths of 40 mg, 80 mg, 120 mg and 160 mg.The USFDA has tentatively approved t…

Moneycontrol en
Stocks IN